Help raise the $505,000 needed for the OPT-Pembro clinical trial, and change treatment for women like Natalie.

“OPT-Pembro could help reduce the amount of treatment and associated side effects – all without compromising patient outcomes.

It would mean some women with triple negative breast cancer could get back to their lives and families sooner.”

– Dr Julia Dixon-Douglas, OPT-Pembro clinical trial Study Co-Chair.

By supporting the OPT-Pembro clinical trial here now, you can help change life for women who have triple negative breast cancer – one of the hardest types to treat.

Please help raise $505,000 by 30 June to fund this promising clinical trial.

Right now, treatment options for women diagnosed with triple negative breast cancer are limited and can come with serious side effects.

Natalie was 42 when she was diagnosed. She remembers that she and her husband, Ross, left the doctor’s office in tears. They had three primary-school-aged children waiting for them at home.

“I can’t die,” Natalie remembers thinking. “I have to stay alive for my children.”

Natalie knew that the treatment ahead of her would be hard. This was her second breast cancer diagnosis. But this time, she had triple negative breast cancer which is aggressive and hard to treat.

The OPT-Pembro clinical trial could help women with breast cancer like Natalie’s have less treatment and still get the same outcome.

Will you please donate here now and get this breast cancer research going?

For women like Natalie, your gift today could mean less treatment, fewer side effects and risks, and a return to their lives and loved ones sooner.

OPT-Pembro has great potential to help stop breast cancer cutting lives short – but only if it’s funded.

Don’t delay. Please make your tax-deductible donation here now, and fund the OPT-Pembro breast cancer clinical trial.